ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selec tivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cyto

Numéro d'article : BIOV2696-5
Unité de mesure : 5 MG
https://grogg-prod.braintec.cloud/web/image/product.template/923729/image_1920?unique=67c7460

133.00 CHF 133.0 CHF 133.00 CHF

133.00 CHF

Not Available For Sale

    Cette combinaison n'existe pas.

    Délai de livraison actuel sur demande

    Fabricant : BIOVISION
    Numéro du fabricant : 2696-5
    Température de stockage : Freezer (-20)

    ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selec tivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cyto